Enzyme-linked immunosorbent assay spot detection of interferon-γ and interleukin 5-producing cells as predictive marker for renal allograft failure

Transplantation

Volumn 66, Issue 2, 1998, Pages 219-224

  Tary Lehmann, Magdalena ^a   Hricik, Donald E ^b   Justice, Amy C ^c   Potter, Nicholas S ^a   Heeger, Peter S ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 5;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FAILURE; LEUKOCYTE MIGRATION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-5; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MITOGENS; PROGNOSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032558139     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807270-00014     Document Type: Article

References (26)

1. Suthanthiran M. Acute rejection of renal allografts: mechanistic insights and therapeutic options. Kidney Int 1997; 51: 1289.
2. Suthanthiran M, Strom T. Renal transplantation. N Engl J Med 1994; 331: 365.
3. Strom T, Roy-Chaudhury P, Manfro R, et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8: 688.
4. Tullius S, Tilney N. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
5. Group OMTS. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985; 313: 337.
6. Reinsmoen N, Matas A. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 1993; 55: 1017.
7. Auchincloss H Jr, Lee R, Shea S, Markowitz J, Grusby M, Glimcher L. The role of indirect recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
8. Braun M, Lowin B, French L, Acha-Orbea H, Tschopp J. Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996; 183: 657.
9. + CTL that utilizes a perform- rather than a Fas ligand-dependent cytotoxic mechanism. J Immunol 1996; 156: 153.
10. Paul W, Seder R. Lymphocyte responses and cytokines. Cell 1994; 76: 241.
11. Mahanty S, King C, Kumaraswami V, et al. IL-4 and IL-5 secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol 1993; 151: 3704.
12. Dallman M, Roake J, Hughes D, Toogood G, Morris P. Sequential analysis of IL-2 gene transcription in renal transplants. Transplantation 1992; 53: 683.
13. Chen N, Field E. Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation 1995; 59: 933.
14. Chen N, Gao Q, Field E. Prevention of TH1 responses is critical for transplantation. Transplantation 1996; 61: 1076.
15. Grant S, Lamb W, Brooks N, Brenchley P, Hutchinson I. Serum cytokines in human heart transplant recipients. Transplantation 1996; 62: 480.
16. Kutukculer N, Clark K, Rigg K, et al. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Transplantation 1995; 59: 333.
17. Keil M, Pec M, Schenn G, et al. Value of serum soluble tumour necrosis factor concentrations in the diagnosis and prognosis of renal graft rejection. Nephrol Dial Transplant 1994; 9: 815.
18. Young J, Windsor N, Smart F, et al. Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation. Transplantation 1991; 51: 636.
19. Xu G-P, Sharma V, Li B, et al. Intragraft TGFβ1 m RNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 1996; 49: 1297.
20. Suthanthiran M. Molecular analyses of human renal allografts: differential intragraft gene expression during rejection. Kidney Int 1997; 51: 815.
21. Merville P, Pouteil-Noble C, Wijdense J, Potaux L, Touraine J, Banchereau J. In situ production of interferon gamma and interleukin 6 by infiltrating cells from human kidney allografts in irreversible rejection: modulation by cytokines. Presse Med 1992; 21: 1966.
22. Dallman M. Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult. Curr Opin Immunol 1995; 7: 632.
23. Reinke P, Fietze E, Ode-Hakim S, et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344: 1737.
24. Tough D, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272: 1947.
25. Acott P, Lee S, Bitter-Suermann H, Lawen J, Crocker J. Infection concomitant with pediatric renal allograft rejection. Transplantation 1996; 62: 689.
26. Tanguay S, Killion J. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine Cytokine Res 1994; 13: 259.